BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dobler CC, Morgan RL, Falck-Ytter Y, Montori VM, Murad MH. Assessing the validity of surrogate endpoints in the context of a controversy about the measurement of effectiveness of hepatitis C virus treatment. BMJ Evid Based Med 2018;23:50-3. [PMID: 29595129 DOI: 10.1136/bmjebm-2017-110852] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Dummer J, Dobler CC, Holmes M, Chambers D, Yang IA, Parkin L, Smith S, Wark P, Dev A, Hodge S, Dabscheck E, Gooi J, Samuel S, Knowles S, Holland AE. Diagnosis and treatment of lung disease associated with alpha one-antitrypsin deficiency: A position statement from the Thoracic Society of Australia and New Zealand. Respirology 2020;25:321-35. [PMID: 32030868 DOI: 10.1111/resp.13774] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Koretz RL, Jakobsen JC, Gluud C. Letter to the editor re: Assessing the validity of surrogate endpoints in the context of a controversy about the measurement of effectiveness of hepatitis C virus treatment. BMJ EBM 2018;23:240-240. [DOI: 10.1136/bmjebm-2018-111072] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
3 Knottnerus JA, Knottnerus BJ. Decision-making given surrogate outcomes. J Clin Epidemiol 2022:S0895-4356(22)00009-9. [PMID: 35041971 DOI: 10.1016/j.jclinepi.2022.01.003] [Reference Citation Analysis]
4 Alahdab F, Zuhri Yafi R, Chaar A, Alrstom A, Alzuabi M, Alhalabi O, Hasan S, Mallak M, Jazayerli ML, Haydour Q, Alkhouli M, Alfarkh W, Murad MH. Aspirin dosage for the prevention of graft occlusion in people undergoing coronary surgery: A systematic review and meta-analysis. Avicenna J Med 2020;10:198-207. [PMID: 33437691 DOI: 10.4103/ajm.ajm_17_20] [Reference Citation Analysis]